PPBT - Purple Biotech logo

PPBT

Purple Biotech

Rev โ€”top 1%10Y
Hold

Purple Biotech develops cancer therapies targeting tumor immune evasion and drug resistance. Its pipeline includes monoclonal antibodies and small molecules in clinical trials for pancreatic cancer and head/neck cancers, among others.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth6.62%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.7
Net Growth-34.03%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth100.00%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-103.22%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend22%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-486.39%
Net Trend36%
Net Income Consistency
Rev Growthโ€”
Rev Trend22%
Revenue Consistency

See the full market ranking โ†’

Purple Biotech fundamental performance

Between 2020 and 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 27M to -$ 26M. Revenue increased in 1 of those 5 years; net income in 2.

Purple Biotech currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.48โ€”
1 Year2025-08-12
$ 22.50-93.42%
5 Years2021-08-12
$ 944.00-99.84%
10 Years2016-08-12
$ 6.12K-99.98%
All Time2015-11-20
$ 6.38K-99.98%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 24M
2025$ 0.00-$ 26M$ 9M
2024$ 0.00-$ 7M$ 8M
2023$ 195.8K-$ 19.88K$ 15M
2022-$ 910K-$ 21M$ 32M
2021-$ 320K-$ 18M$ 47M
2020$ 1M-$ 27M$ 57M
2019$ 1M-$ 5M$ 6M
2018$ 1M-$ 5M$ 5M
2017$ 100K-$ 12M$ 3M
2016-$ 12M$ 14M
IPO2015-$ 4M$ 10M

Explore beyond PPBT

You're looking at Purple Biotech. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies